MoneyWorks4Me

Hester Biosciences board to consider financial results

08 Aug 2012 Evaluate
Hester Biosciences has informed that a meeting of the board of directors of the company will be held on August 14, 2012, to consider the audited financial result for the year 2011-2012 and also the unaudited financial result for the quarter ended on June 30, 2012.

Further, considering the 25th year of the company, the board of directors shall discuss and consider proposal for bonus shares to be issued to existing shareholders of the company.

The above information is a part of company's filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1850.20
Dr. Reddys Labs. 1210.65
Cipla 1374.50
Lupin 2095.55
Zydus Lifesciences 1162.00
View more..